Evidence map›Paper›PMID 40553465›Full record

Observational studyMedical decision making : an international journal of the Society for Medical Decision Making2025

Association between Exposure to Statin Choice and Adherence to Statins: An Observational Cohort Study.

Kathryn A Martinez, Victor M Montori, Fatima Rodriguez, Larisa G Tereshchenko, Jeffrey D Kovach, Christopher Boyer, Heather McKee Hurwitz, Michael B Rothberg

Abstract readObservational Study
In one paragraph

Observational study in Medical decision making : an international journal of the Society for Medical Decision Making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kathryn A MartinezCleveland Clinic Center for Value-Based Care Research, Cleveland, OH, USA.ORCID 0000-0001-9177-480X
Victor M MontoriKnowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0003-0595-2898
Fatima RodriguezDivision of Cardiovascular Medicine, the Cardiovascular Institute, and the Center for Digital Health, Stanford University School of Medicine, Stanford, CA, USA.
Larisa G TereshchenkoCleveland Clinic, Lerner Research Institute, Department of Quantitative Health Sciences, Cleveland, OH, USA.ORCID 0000-0002-6976-1313
Jeffrey D KovachCleveland Clinic, Lerner Research Institute, Department of Quantitative Health Sciences, Cleveland, OH, USA.
Christopher BoyerCleveland Clinic, Lerner Research Institute, Department of Quantitative Health Sciences, Cleveland, OH, USA.
Heather McKee HurwitzCleveland Clinic Taussig Cancer Center, Cleveland, OH, USA.
Michael B RothbergCleveland Clinic Center for Value-Based Care Research, Cleveland, OH, USA.

Funding

Improving Adherence with Statins Through Use of the Statin Choice Decision AidR56HL164379 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI MARTINEZ, KATHRYN ANNE · 2022 to 2022
$535k
American Heart Association-American Stroke Association 23IPA1054947American Heart Association-American Stroke Association 23TPA1141088NHLBI NIH HHS R56 HL164379
6 · The paper itself

Abstract

BackgroundStatin Choice is a shared decision-making encounter tool embedded in the electronic health record.ObjectiveTo describe the association between the use of Statin Choice, statin prescriptions by clinicians, prescription fills (primary adherence), and statin adherence at 12 mo (secondary adherence).DesignObservational cohort study at the Cleveland Clinic Health System.SubjectsStatin-naïve adults aged 40 to 75 y with a 10-y atherosclerotic cardiovascular disease (ASCVD) risk of ≥5% and a primary care appointment between January 2020 and July 2021.Main MeasuresThe primary exposure was the use of Statin Choice during a clinical encounter. We measured whether the use of Statin Choice was associated with statin prescriptions. We measured statin adherence based on pharmacy fill data at 60 d (primary adherence) and 12 mo (secondary adherence). We used mixed-effects logistic regression to estimate the adjusted odds of statin prescriptions and adherence at the 3 time points by the use of Statin Choice.Key ResultsAmong 17,001 statin-naïve patients, 13% viewed Statin Choice and 7% were prescribed a statin. The median ASCVD risk was 10%. Patients who were shown Statin Choice had 9.04 higher odds of being prescribed a statin compared with patients not shown Statin Choice (95% confidence interval [CI]: 7.86-10.4). Among patients prescribed a statin, the use of Statin Choice was associated with 5.75 higher odds of primary adherence compared with usual care (95% CI: 4.22-7.83). At 12 mo, Statin Choice use was significantly associated with adherence in the unadjusted analysis (OR: 1.58; 95% CI: 1.05-2.08) but was not significant after adjustment for patient factors. Patients shown Statin Choice had an average of 12 mg/dL reduction in low-density lipoprotein cholesterol at 12 mo (95% CI: -16 mg/dL, -10) compared with those not shown Statin Choice.ConclusionIn this observational study, Statin Choice use was strongly associated with statin prescription and fills and weakly associated with adherence to statins for up to 1 y. A randomized trial is needed to confirm causality.HighlightsStatin Choice is an electronic health record-embedded shared decision-making encounter tool available for free in many health care systems.Small randomized controlled trials have found modest associations between the use of Statin Choice and statin adherence using patient-reported data.In our large study using pharmacy fill data, clinician use of Statin Choice during a medical encounter was associated with significantly greater patient adherence with statins up to 1 y later.Exposure to Statin Choice was associated with a significant reduction in low-density lipoprotein cholesterol over 1 y.

Indexed as

Hydroxymethylglutaryl-CoA Reductase InhibitorsMedication AdherenceAdultAgedCohort StudiesFemaleHumansMaleMiddle AgedHydroxymethylglutaryl-CoA Reductase Inhibitorsadherencedecision aidsrisk communicationshared decision makingstatins

Identifiers

PMID40553465
PMCPMC12354097

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.